Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in FATE — Fate Therapeutics Inc

CIK 1446194 BALA CYNWYD, PA
Back to FATE Full portfolio

Position in FATE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,379,835
+$1,021,640 QoQ
Shares Held
511,050
+71.2% QoQ
Ownership
0.427%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 156 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FATE Over Time

Shares Held

Position Value (USD)

Derivatives in FATE

reported options exposure · as of Jun 30, 2026
CallValue
$166,860
CallShares
61,800
PutValue
$267,840
PutShares
99,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. FATE ranks #110 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in FATE

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,379,835 511,050
2026-06-30 $166,860 61,800
2026-06-30 $267,840 99,200
2026-03-31 $60,600 50,500
2026-03-31 $37,800 31,500
2026-03-31 $358,195 298,496
2025-12-31 $303,987 310,191
2025-12-31 $74,382 75,900
2025-09-30 $225,448 178,927
2025-06-30 $110,096 98,300
2025-06-30 $323,939 289,232
2025-03-31 $140,114 177,360
2024-12-31 $177,233 107,414
2024-12-31 $42,075 25,500
2024-09-30 $198,663 56,761
2024-06-30 $39,032 11,900
2024-06-30 $174,801 53,293
2024-03-31 $286,260 39,000
2024-03-31 $448,474 61,100
2024-03-31 $685,085 93,336
2023-12-31 $570,383 152,509
2023-09-30 $922,479 435,132
2023-06-30 $151,368 31,800
2023-06-30 $2,310,302 485,358
2023-03-31 $58,710 10,300
2023-03-31 $4,971,618 872,214
2022-12-31 $369,465 36,617
2022-12-31 $282,520 28,000
2022-09-30 $273,402 12,200
2022-09-30 $2,829,083 126,242
2022-09-30 $468,369 20,900
2022-06-30 $2,391,270 96,500
2022-06-30 $2,883,202 116,352
2022-06-30 $364,266 14,700
2022-03-31 $1,093,314 28,200
2022-03-31 $1,954,008 50,400
2022-03-31 $2,125,100 54,813
2021-12-31 $6,213,937 106,203
2021-12-31 $1,708,492 29,200
2021-12-31 $2,328,698 39,800
2021-09-30 $8,931,989 150,700
2021-09-30 $2,430,070 41,000
2021-09-30 $5,109,903 86,214
2021-06-30 $5,840,967 67,300
2021-06-30 $2,864,763 33,008
2021-06-30 $6,075,300 70,000
2021-03-31 $3,475,844 42,157
2021-03-31 $9,564,200 116,000
2021-03-31 $9,267,380 112,400
2020-12-31 $4,646,523 51,100